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Shiga toxins (Stxs) induce apoptosis in a variety of cell types. Here, we show that Stx1 induces apoptosis in
the undifferentiated myelogenous leukemia cell line THP-1 in the absence of tumor necrosis factor alpha
(TNF-) or death receptor (TNF receptor or Fas) expression. Caspase-8 and -3 inhibitors blocked, and
caspase-6 and -9 inhibitors partially blocked, Stx1-induced apoptosis. Stx1 induced the mitochondrial pathway
of apoptosis, as activation of caspase-8 triggered the (i) cleavage of Bid, (ii) disruption of mitochondrial
membrane potential, and (iii) release of cytochrome c into the cytoplasm. Caspase-8, -9, and -3 cleavage and
functional activities began 4 h after toxin exposure and peaked after 8 h of treatment. Caspase-6 may also
contribute to Stx1-induced apoptosis by directly acting on caspase-8. It appears that functional Stx1 holotoxins
must be transported to the endoplasmic reticulum to initiate apoptotic signaling through the ribotoxic stress
response. These data suggest that Stxs may activate monocyte apoptosis via a novel caspase-8-dependent, death
receptor-independent mechanism.
Shiga toxins (Stxs) are a family of protein exotoxins ex-
pressed by the enteric pathogens Shigella dysenteriae serotype 1
and certain serotypes of Escherichia coli. Stxs share structural
and functional properties: Stxs are holotoxins composed of a
single A-subunit in noncovalent association with a pentameric
ring of identical B-subunits, and the toxins are potent protein
synthesis inhibitors in susceptible mammalian cells (11, 31).
The B-subunits mediate toxin binding through interaction with
the neutral membrane glycolipid globotriaosylceramide (Gb3)
(24). Following internalization and retrograde transport of the
toxins through the Golgi apparatus to the endoplasmic reticu-
lum (ER), A-subunits are proteolytically nicked and reduced,
and the resultant A1-fragments are translocated into the target
cell cytoplasm (38). The A1-fragment acts as a highly specific
N-glycosidase that cleaves a single adenine residue near the 3
end of the 28S rRNA component of eukaryotic ribosomes (8,
39). Shigella dysenteriae serotype 1 produces Shiga toxin (Stx),
while E. coli may express multiple toxins categorized as Shiga
toxin type 1 (Stx1) or Shiga toxin type 2 (Stx2), based on their
antigenic similarity to Stx (27).
Shigella dysenteriae serotype 1 and Shiga toxin-producing E.
coli cause the bloody diarrheal diseases bacillary dysentery and
hemorrhagic colitis, respectively. Patients infected with Stx-
producing bacteria are at increased risk for developing life-
threatening complications, including acute renal failure (he-
molytic uremic syndrome) and central nervous system
abnormalities such as disorientation, lethargy, seizures, paral-
ysis, coma, and death (34, 40). Numerous studies in animals
have shown that the extra-intestinal complications seen in hu-
mans are reproduced by the intravenous administration of
purified Stxs (29). Affected organs in humans and experimental
animals show evidence of profound vascular damage. These
observations suggest that Stxs gain access to the bloodstream
and target vascular endothelial cells in the kidneys and central
nervous system for destruction. In addition to direct cytotoxic
effects on endothelial cells, Stxs have also been shown to stim-
ulate macrophages to produce the proinflammatory cytokines
tumor necrosis factor alpha (TNF-) and interleukin-1 in
vitro (35, 48). These cytokines, in turn, up-regulate Gb3 bio-
synthesis and expression on endothelial cells (47) and sensitize
target cells to the cytotoxic action of the toxins (25). Thus, the
host innate immune response may exacerbate vascular damage
initiated by Stxs.
Stxs have been demonstrated to induce apoptosis in many
human cell types in vitro, including epithelial cell lines, primary
renal epithelial cells, Burkitt’s lymphoma cells, microvascular
endothelial cells, and myelogenous leukemia cell lines (re-
viewed in reference 6). The mechanism(s) by which Stxs induce
apoptosis in these cell types, and whether a common apoptosis
pathway is triggered by Stxs in all cell types, remains to be fully
characterized. Kojio et al. (21) showed that Stx-induced apo-
ptosis in the human monocytic cell line THP-1 required trans-
port of toxins through functional Golgi complexes and the
activation of caspase-3. Fujii et al. (12) reported that Stx-
induced HeLa cell apoptosis occurs via a pathway requiring
caspase-8, -6, and -3, but not caspase-9. In contrast to studies
using holotoxin molecules, binding toxin receptors with puri-
fied Stx B-subunits or anti-Gb3 antibodies has been reported to
be sufficient to induce caspase-8 activation and apoptosis in
Burkitt’s lymphoma cells (20). Finally, it is unknown whether
Stxs directly activate apoptosis in all cell types or if additional
host factors are required in some instances. One potential host
factor that may contribute to apoptosis induction is TNF-
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(49). We previously showed that purified Stx1 induces TNF-
and interleukin-1 gene expression and apoptosis in the my-
elomonocytic cell line THP-1 in a cell maturation-dependent
manner (14, 15). Differentiated (macrophage-like) THP-1 cells
were relatively resistant to killing by Stxs and expressed cyto-
kines, whereas undifferentiated (monocytic) THP-1 cells failed
to secrete TNF- and were sensitive to Stx cytotoxicity. Plastic-
adherent human peripheral blood monocytes, like differenti-
ated THP-1 cells, were relatively insensitive to apoptosis in-
duction by Stx2 but responded by producing TNF- and
granulocyte-macrophage colony-stimulating factor (5). Thus,
there appears to be a Stx-dependent, TNF--independent ap-
optotic signaling mechanism operative in monocytic THP-1
cells. Experiments reported here characterize Stx1-mediated
apoptotic signaling in monocytic THP-1 cells.
MATERIALS AND METHODS
Cells. The human myelogenous leukemia cell line THP-1 (46) was purchased
from the American Type Culture Collection, Manassas, VA, and cultured in
RPMI 1640 medium (Gibco-BRL, Grand Island, NY) supplemented with pen-
icillin (100 U/ml), streptomycin (100 g/ml), and 10% fetal bovine serum (FBS;
HyClone Laboratories, Logan, UT). Cells were maintained at 37°C in 5% CO2
in a humidified incubator.
Toxins. Stx1 used in this study was prepared as previously described (44).
Briefly, Stx1 was purified from cell lysates prepared from E. coli
DH5(pCKS112) cells by sequential ion-exchange, chromatofocusing, and im-
munoaffinity chromatography. Purity of toxin preparations was assessed by so-
dium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) with sil-
ver staining and Western blot analysis using anti-Stx1 antibodies. Toxin
preparations contained 0.1 ng endotoxin per ml as determined by Limulus
amoebocyte lysate assay (Associates of Cape Cod, Falmouth, ME). Purified Stx1
pentameric B-subunits were the kind gift of Cheleste Thorpe, Tufts University
School of Medicine, Boston, MA. Purified Stx1A (E167Q-R170L), an enzy-
matic mutant in which glutamate at position 167 and arginine at position 170
were replaced by glutamine and leucine, respectively, by oligonucleotide-directed
site-specific mutagenesis (32), was the kind gift of Yoshifumi Takeda, Jissen
Women’s University, Tokyo, Japan.
Reagents. General caspase inhibitor N-benzyl-oxycarbonyl-Val-Ala-Asp-
(OMe)-fluoromethyl-ketone (ZVAD-fmk), caspase-1 inhibitor Z-Tyr-Val-Ala-
Asp-fmk (Z-YVAD-fmk), caspase-2 inhibitor Z-Val-Asp-Val-Ala-Asp-fmk (Z-
VDVAD-fmk), caspase-3 inhibitor Z-Asp-Glu-Val-Asp-fmk (Z-DEVD-fmk),
caspase-6 inhibitor Z-Val-Glu-Ile-Asp-fmk (Z-VEID-fmk), caspase-8 inhibitor
Z-Ile-Glu-Thr-Asp-fmk (Z-IETD-fmk), and caspase-9 inhibitor Z-Leu-Glu-His-
Asp-fmk (Z-LEHD-fmk) were purchased from Calbiochem, San Diego, CA. All
caspase inhibitors were used at concentrations known to optimally inhibit specific
caspase activity. Rabbit anti-human cytochrome c antibody was purchased from
San Cruz Biotechnology, Inc., Santa Cruz, CA. Antibodies directed against
human caspase-3, caspase-8, caspase-9, and Bid were obtained from Cell Signal-
ing Technology, Beverly, MA. Cycloheximide and anisomycin were purchased
from Sigma, St. Louis, MO. Fluorescein-conjugated and nonfluoresceinated
monoclonal antibodies directed against human membrane-bound TNF-, TNF
receptor 1 (TNFR1), TNFR2, and Fas (APO/CD95) were purchased from R&D
Systems, Inc., Minneapolis, MN. Human immunoglobulin G (IgG) and all other
reagents were obtained from Sigma Chemical Co., St. Louis, MO.
Analysis of cell surface receptor expression. THP-1 cells (2  106 cells/ml)
were incubated in the presence or absence of Stx1 (400 ng/ml) for 0, 2, 4, and 6 h.
We have previously shown that this toxin concentration produces optimal sig-
naling for cytokine expression and apoptosis induction (14, 15). Cells were
washed twice with phosphate-buffered saline (PBS) containing 0.5% bovine
serum albumin (BSA). Before staining for cell surface receptor expression using
antibodies, Fc	Rs were blocked by treatment of the cells with 1.0 g of human
IgG per 105 cells for 15 min at room temperature. Fc	R-blocked cells were
washed and suspended in PBS plus 0.5% BSA. Cells were then treated with
fluorescein-conjugated monoclonal antibodies directed against human mem-
brane-bound TNF- (mTNF-), TNFR1, TNFR2, or Fas for 30 to 45 min at 4°C.
Following incubation, cells were washed and suspended in 0.5 ml PBS. Cell
fluorescence was measured by flow cytometry using the FACSCalibur instrument
(Becton Dickinson, Palo Alto, CA). Untreated cells and cells treated with fluo-
rescein-labeled mouse IgG antibodies (Santa Cruz Biotechnology, Inc., Santa
Cruz, CA) served as control cells in the fluorescence-activated cell sorter (FACS)
analysis.
Analysis of apoptosis by Annexin V and PI staining. THP-1 cells were treated
with Stx1 (400 ng/ml) for 12 h in RPMI 1640 plus 0.5% FBS in the presence or
absence of anti-human TNF- antibody (0.01 g/ml), anti-human TNFR1 anti-
body (5.0 g/ml), or recombinant human TNF- (rhTNF-; 40 ng/ml). In a
separate set of experiments, cells were treated with Stx1 for 5 h in RPMI 1640
plus 0.5% FBS in the presence or absence of caspase-1, -2, -3, -6, -8, and -9
inhibitors or the general caspase inhibitor ZVAD-fmk (all at 40 M). In some
experiments, THP-1 cells were treated with cycloheximide (10 to 200 M) or
anisomycin (0.1 to 10 g/ml) for 5 h. Following treatment, cells were centrifuged
at 200  g for 5 min, washed in ice-cold sterile PBS, and stained using the
Annexin V-FLUOS staining kit (Roche Diagnostics Corp., Indianapolis, IN).
Cells were incubated in the provided incubation buffer for 10 to 15 min at room
temperature. Cells were then centrifuged, washed twice in incubation buffer, and
suspended in 0.5 ml of incubation buffer. Apoptosis was measured by flow
cytometry (Becton Dickinson, Palo Alto, CA). Fluorescence parameters were
gated using unstained and single-stained untreated cells. Total apoptosis was
expressed as the percentages of Annexin V-positive plus Annexin V and pro-
pidium iodide (PI) double-positive cells minus background fluorescence.
DNA fragmentation analysis. DNA fragmentation was assayed using the Ap-
optotic DNA Ladder kit (Roche, Mannheim, Germany). THP-1 cells (2  106
cells/ml) were maintained in 12-well culture plates. Cells were treated with Stx1
(400 ng/ml) in RPMI 1640 and 0.5% FBS in the presence or absence of
caspase-1, -2, -3, -6, -8, and -9 inhibitors or the general caspase inhibitor ZVAD-
fmk (all at 40 M) for 5 h. Cells were washed with ice-cold PBS and lysed with
lysis buffer (6.0 M guanidine-HCl, 10 mM urea, 10 mM Tris-HCl, 20% Triton
X-100 [vol/vol], pH 4.4). After 10 min of incubation at room temperature, lysates
were centrifuged through DNA binding columns. DNA was eluted from the
columns with 10 mM Tris (pH 8.5). Eluted DNA was treated with DNase-free
RNase for 30 min. DNA concentrations were measured, and equal amounts of
DNA (2.5 g) were loaded on 1.2% agarose gels. Following electrophoresis, gels
were stained with ethidium bromide and photographed on a UV transilluminator
(Gel Imager; Bio-Rad, Hercules, CA).
Preparation of cellular lysates. Prior to stimulation with Stx1, THP-1 cells (5
 106 cells/ml) were washed once in cold Dulbecco’s PBS and suspended in
RPMI 1640 with 0.5% FBS for 2 h. Cells were then stimulated with Stx1 (400
ng/ml) for the various time periods indicated in the figures. For Western blot
analyses of caspase and Bid activation, cells were harvested and lysed with
modified radioimmunoprecipitation assay buffer (1.0% Nonidet P-40, 1.0% Na-
deoxycholate, 150 mM NaCl, 50 mM Tris-HCl [pH 7.5], 0.25 mM Na-pyrophos-
phate, 2.0 mM Na-vanadate, 2.0 mM Na-fluoride, 10 g/ml aprotinin, 1.0 g/ml
leupeptin, 1.0 g/ml pepstatin, and 200 mM phenylmethylsulfonyl fluoride) at
4°C. Extracts were collected and cleared by centrifugation at 15,000  g for 10
min. Cleared extracts were stored at 80°C until used in Western blot analyses.
For measurement of cytochrome c release from mitochondria, cytosolic fractions
were prepared according to the method of Leist et al. (22). THP-1 cells (5  107
cells/ml) were stimulated with Stx1 as outlined above. Cells were harvested and
suspended for 20 min at 4°C in permeabilization buffer (pH 7.2) containing 210
mM D-mannitol, 70 mM sucrose, 10 mM HEPES, 5.0 mM succinate, 0.2 mM
EGTA, 0.15% BSA, and 80 g/ml digitonin. Cells were centrifuged at 170 g for
10 min at 4°C. Supernatants were collected and centrifuged at 13,000  g for 10
min at 4°C. The resultant supernatants (cytosolic fraction) were used for cyto-
chrome c analysis by Western blotting.
Western blot analysis of caspase activation, Bid cleavage, and cytochrome c
release. The protein content of cell extracts and cytosolic fractions was deter-
mined using the Micro BCA protein assay kit (Pierce, Rockford, IL). Equal
amounts of proteins (60 to 80 g protein per gel lane) were separated by 12%
Tris-glycine SDS-PAGE and transferred to nitrocellulose membranes. The mem-
branes were blocked with 5% milk prepared in TBST (20 mM Tris [pH 7.6], 137
mM NaCl, 0.1% Tween 20). Membranes were incubated with primary antibodies
specific for human caspases, cytochrome c, or Bid in 5.0% BSA–TBST overnight
at 4°C. The membranes were then incubated with the corresponding secondary
antibodies (rabbit or mouse anti-IgG coupled to horseradish peroxidase) for 2 h
at room temperature. Bands were visualized using the Western Lightning chemi-
luminescence system (NEN–Perkin-Elmer, Boston, MA). Data shown are from
at least two independent experiments.
Analysis of mitochondrial membrane potential. Alterations in mitochondrial
membrane potential were measured using the mitochondrial membrane poten-
tial detection kit (Stratagene, La Jolla, CA). The mitochondrial membrane
potential maintained in healthy cells allows the positively charged JC-1 reagent
(5,5,6,6-tetraachloro-1,1,3,3-tetraethylbenz-imidazolocarbocyanine iodide) to
accumulate in mitochondrial membranes, forming aggregates with red fluores-
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cence. In apoptotic cells, as the mitochondrial membrane potential is disrupted,
JC-1 does not accumulate in the membranes, and JC-1 in the cytoplasm has a
green fluorescence. THP-1 cells (2  106 cells/ml) in 12-well culture plates were
treated with Stx1 (400 ng/ml) in RPMI 1640 plus 0.5% FBS in the presence or
absence of 40 M caspase-1, -2, -3, -6, -8, and -9 inhibitors or ZVAD-fmk for 0,
2, 4, 6, and 8 h. Cells were harvested, washed in ice-cold PBS, and resuspended
in 0.5 ml JC-1 assay buffer containing the JC-1 reagent. Following incubation for
15 min at 37°C in 5% CO2, the cells were centrifuged at 400  g for 5 min and
washed twice in assay buffer. Washed cells were resuspended in 0.5 ml of assay
buffer, and maintenance of JC-1 in the mitochondrial membrane was assessed by
flow cytometry.
Measurement of caspase activity. Caspase activity was determined using
caspase assay kits purchased from Chemicon, Temecula, CA, with colorimetric
substrates for caspase-3 (Ac-DEVD-pNA), caspase-8 (Ac-IETD-pNA), and
caspase-9 (Ac-LEHD-pNA). THP-1 cells (5 106 cells/ml) were treated with the
caspase inhibitors (40 M) for 1 h prior to the addition of Stx1 (400 ng/ml). At
various time points after toxin stimulation, cells were washed in ice-cold PBS,
treated with lysis buffer provided with the kits, and maintained on ice for 20 min.
Cell lysates were centrifuged, and protein concentrations in the supernatants
were determined using the Bio-Rad Dc protein assay kit (Bio-Rad, Hercules,
CA). Equal amounts of protein (60 g per reaction mixture) were added to the
caspase assay buffer and incubated for 2 h at 37°C. Caspase activation resulted in
cleavage of the substrates, releasing free p-nitroaniline (pNA), which was de-
tected spectrophotometrically (405 nm) in a microtiter plate reader. Caspase
activity is expressed as pM pNA liberation per minute per g protein. The data
shown are the means 
 standard errors of the means determined from three
independent assays.
Statistics. Statistical analyses of experiments were performed with Excel (Mi-
crosoft, Corp., Redmond, WA). All Annexin V/PI staining, Bid cleavage, and
caspase activity data were analyzed by using Student’s t test.
RESULTS
Roles of TNFR1, TNFR2, and Fas in Stx1-induced apopto-
sis. Members of the TNFR family and Fas (APO/CD95) trans-
duce apoptotic signals following engagement with their appro-
priate ligands. We investigated, therefore, whether TNFR1,
TNFR2, or Fas is involved in Stx1-induced apoptosis of mono-
cytic THP-1 cells. Following exposure to Stx1 for 6 h, mem-
brane expression of TNFR1, TNFR2, mTNF- (reported to
specifically bind to TNFR2 [49]), and Fas was measured by
flow cytometry (Fig. 1A). We failed to detect the expression of
mTNF- or death receptors on Stx1-treated cells. Control
monocytic THP-1 cells cultured without Stx1 also failed to
express death receptors. As a positive control, treatment of
cells with phorbol-12-myristate-13-acetate induced the mem-
brane expression of TNFR1, TNFR2, and mTNF- (data not
shown). Treatment of cells with Stx1 for 12 h resulted in 82.1

 4.9% apoptosis as measured by Annexin V and PI staining
(Fig. 1B). In keeping with the lack of death receptor expres-
sion, purified rhTNF- (40 ng/ml) failed to induce apoptosis in
THP-1 cells. Pretreatment of cells with anti-TNFR1 or anti-
TNF- neutralizing antibodies did not prevent apoptosis in-
duced by Stx1. Treatment of cells with the antibodies alone did
not significantly affect cell viability. FasL has been reported to
be constitutively produced and stored within THP-1 cells (4),
and Tsan et al. (45) demonstrated that binding of a FasL
agonist did not affect THP-1 cell growth. Collectively, these
data suggest that Stx1-mediated cell death of monocytic THP-1
cells occurs through a TNFR/Fas-independent mechanism.
Requirement for caspase-8 and -3 activation for Stx1-in-
duced apoptosis. The sequential activation of a cascade of
cysteine-dependent aspartate-specific proteases, called caspases,
constitutes a major component of the programmed cell death
machinery (43). In previous studies, we showed that Stx1-
induced apoptosis of THP-1 cells was blocked by the general
caspase inhibitor ZVAD-fmk (14). To further clarify the
caspases required for Stx1-induced apoptosis, we measured
apoptosis in the presence of specific caspase inhibitors using
two different assays: DNA fragmentation and FACS analysis
with Annexin V and PI double staining. In addition to ZVAD-
fmk, the caspase-8-specific inhibitor and, to a lesser extent, the
caspase-3-specific inhibitor were most effective in preventing
Stx1-induced DNA laddering (Fig. 2A). Furthermore, inhibi-
tion of DNA fragmentation occurred in a caspase-8 inhibitor
dose-dependent manner (Fig. 2B). Figure 3A shows represen-
tative scatter plots of FACS analyses of Annexin V/PI-stained
FIG. 1. (A) Effect of Stx1 on death receptor expression by THP-1
cells. THP-1 cells were untreated (0 h) or treated with Stx1 (400 ng/ml)
for 2, 4, and 6 h. After FcR blocking with human IgG (1.0 g/105 cells),
cells were incubated with anti-TNFR1, anti-TNFR2, anti-mTNF-,
anti-Fas, or control mouse IgG antibodies. Death receptor expression
was assessed by flow cytometry. Representative results from three
independent experiments are shown for untreated cells (shaded histo-
gram) and 6-h Stx1 treatment (solid line). (B) Role of death receptors
in Stx1-mediated apoptosis. THP-1 cells were untreated or treated
with rhTNF- for 12 h or pretreated with neutralizing anti-TNFR1 or
anti-TNF- antibodies for 1 h followed by treatment with Stx1 (400
ng/ml) for 12 h. Cells were stained with Annexin V and PI and ana-
lyzed by flow cytometry. Percentages of apoptotic (Annexin V-positive
plus Annexin V/PI double-positive cells) were determined. Data shown
are means 
 standard errors of the means from three independent
experiments. *, a significant difference (P  0.01) relative to control
(untreated) cells.
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cells treated with Stx1 with or without pretreatment with spe-
cific caspase inhibitors. Percentages of total apoptosis ([An-
nexin V-positive cells  Annexin V/PI double-positive cells] –
background fluorescence) from three independent experi-
ments are shown in Fig. 3B. After 5 h exposure to Stx1, 20.9 

3.3% of THP-1 cells were Annexin V or Annexin V/PI positive.
Caspase-3 and -8 inhibitors almost completely blocked apopto-
sis (4.3 
 2.5% and 3.55 
 2.7%, respectively; P  0.01).
Caspase-6 and -9 inhibitors were partially effective in blocking
Stx1-induced apoptosis, reducing Annexin V and Annexin
V/PI positivity by approximately 50% (10.5 
 2.1% and 10.1 

0.9%, respectively; P  0.01). Caspase-1 and -2 inhibitors did
not significantly decrease DNA laddering or Annexin V/PI
staining. These data show that Stx1 triggers apoptosis in mono-
cytic THP-1 cells primarily through activation of caspase-3 and
-8, although caspase-6 and -9 also contribute to apoptosis in-
duction.
Activation of the mitochondrial pathway of apoptosis
through Bid cleavage. Cleavage of caspase-8 may directly ac-
FIG. 2. (A) Effect of caspase inhibitors on Stx1-induced DNA frag-
mentation in THP-1 cells. Cells were incubated with specific caspase
inhibitors (caspase-1 inhibitor [C1I], etc.) for 1 h and then treated with
Stx1 (400 ng/ml) for 5 h. All caspase inhibitors were used at 40 M.
DNA was isolated and analyzed by ethidium bromide-agarose gel
electrophoresis. ZVAD-fmk is a general caspase inhibitor. (B) A
caspase-8 inhibitor (Z-IETD-fmk) blocks Stx1-induced DNA fragmen-
tation in a dose-dependent manner. THP-1 cells were pretreated with
the indicated concentrations of a caspase-8 inhibitor (C8I) for 1 h prior
to the addition of Stx1 for 5 h. DNA was isolated and analyzed by
ethidium bromide-agarose gel electrophoresis. “DNA ladder” is an
apoptosis DNA ladder marker.
FIG. 3. Effect of specific caspase inhibitors on Stx1-induced apo-
ptosis of THP-1 cells. Cells (2  106 cells/ml) were incubated with
various caspase inhibitors (all at 40 M) for 1 h and then treated with
Stx1 (400 ng/ml) for 5 h. Cells were stained with Annexin V and PI and
analyzed by flow cytometry. (A) Representative scatter plots showing
percentages of cells staining Annexin V positive (lower right quad-
rants) or Annexin V/PI double positive (upper right quadrants).
(B) Percentages of total apoptosis of THP-1 cells treated with specific
caspase inhibitors and Stx1. Data shown are the means 
 standard
errors of the means from three independent experiments. *, a signif-
icant difference (P  0.01) relative to Stx1 treatment.
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tivate caspase-3 or initiate apoptosis through the mitochon-
drial pathway (16). Caspase-8 converts the inactive 22-kDa
form of Bid, a proapoptotic BH3 domain-only member of the
Bcl2 family, to the active 15-kDa form called truncated Bid
(tBid). tBid associates with the mitochondrial outer mem-
brane, disrupts mitochondrial membrane potential (m), and
releases cytochrome c into the cytoplasm. Release of cyto-
chrome c leads to the formation of a multimeric complex, the
apoptosome, and the activation of caspase-9 (16, 53). To in-
vestigate possible activation of the mitochondrial pathway,
THP-1 cells were incubated with Stx1 for 0 to 8 h, and Bid
cleavage, m, and cytochrome c release were measured (Fig.
4). As shown in Fig. 4A, levels of immunoreactive cytosolic Bid
decreased beginning 4 h after Stx1 treatment. Densitometric
scanning of the bands revealed a 50% reduction in the inactive
form of Bid at 8 h of toxin treatment (P  0.02). To measure
m, THP-1 cells stained with the dye JC-1 were analyzed by
flow cytometry (Fig. 4B). At the start of the experiment and 2 h
FIG. 4. Kinetics of Bid cleavage, reduction in m, and cytochrome c release in Stx1-treated THP-1 cells. Cells were harvested at 0, 1, 2, 4,
6, and 8 h after Stx1 treatment. (A) Cell lysates were prepared, and the uncleaved (22-kDa) form of Bid was detected in the lysates by
immunoblotting (upper panel). Levels of Bid were quantitated by densitometric scanning and compared to control levels (lower panel). Data shown
are the means 
 standard errors of the means from two independent experiments. *, a significant difference (P  0.02) compared to control cells.
(B) Cells were collected after Stx1 treatment, and the JC-1 reagent was used to measure reductions in m by flow cytometry. Percentages of cells
staining for red and green fluorescence (upper right quadrants) and red fluorescence only (lower right quadrants) are shown in the upper
right-hand corners of the quadrants. A decrease in m is associated with a shift in reactive cells from the upper right quadrant to the lower right
quadrant. Representative scatter plots from two independent experiments are shown. (C) Cytosolic fractions were prepared, and cytochrome c was
detected in the fractions by immunoblotting. A representative blot from two independent experiments is shown.
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after toxin stimulation, JC-1 accumulated in the mitochondrial
membrane as evidenced by 97% of the cells staining positive
for red and green fluorescence. Beginning 4 h after Stx1 treat-
ment, red fluorescence was reduced, and at 6 and 8 h of toxin
treatment, m was markedly reduced. Cytosolic fractions
prepared from THP-1 cells treated with Stx1 for 0 to 8 h were
analyzed by immunoblotting for the presence of cytochrome c
(Fig. 4C). No cytochrome c was detected in the cytoplasm until
6 h after Stx1 treatment.
To more directly examine the relationship between
caspase-8 activation and m, we treated THP-1 cells with the
caspase-8 inhibitor or ZVAD-fmk and then treated with Stx1
for 8 h. Levels of JC-1 red fluorescence were then determined
by flow cytometry (Fig. 5). Treatment with the caspase inhib-
itors almost completely blocked m. These data suggest that
Stx1 induces apoptosis, in part, through the activation of
caspase-8, the cleavage of Bid, alterations in mitochondrial
membrane potential, and the release of cytochrome c.
Kinetics of Stx1-induced caspase activation. Because Stx1-
induced apoptosis of THP-1 cells required caspase-3, -8, and
-9, we examined the kinetics of activation of these three
caspases over a 24-h period of toxin stimulation. Caspase ac-
tivation was monitored using caspase-specific colorimetric sub-
strates coupled to pNA. Active caspases cleave the substrate,
releasing free pNA. As shown in Fig. 6A, caspase-3, -8, and -9
showed similar kinetics of activation. Activities were signifi-
cantly elevated (P 0.05) 4 h after toxin treatment and peaked
at 8 h. By 24 h, caspase activities appeared to return to basal
levels. However, we have previously shown that approximately
85% of monocytic THP-1 cells treated with Stx1 for 24 h are
not viable (14). The kinetics of caspase cleavage from the
inactive procaspases were measured by Western blotting (Fig.
6B). The kinetics of caspase cleavage closely correlated with
kinetics of functional activation.
Role of caspase-6 in Stx1-induced apoptosis. Although we
showed that Stx1-induced apoptosis of THP-1 cells was asso-
ciated with caspase-8 activation and the subsequent triggering
of the mitochondrial pathway of cell death, we also noted that
a caspase-6 inhibitor reduced Stx1-mediated apoptosis by ap-
proximately 50% (Fig. 3B). Caspase-3 has been reported to
activate caspase-8 through a mitochondria-independent,
caspase-6-dependent mechanism (13). Therefore, we investi-
gated the role of caspase-6 in Stx1-induced apoptosis. THP-1
cells were treated with caspase-3, -6, and -8 inhibitors (40 M)
for 1 h prior to the addition of Stx1 (Fig. 7A). As expected,
pretreatment of cells with the caspase-8 inhibitor dramatically
reduced caspase-3, -8, and -9 activities, suggesting that
caspase-8 activation may be an upstream event of caspase-3
and -9 activation. However, treatment of cells with caspase-3
and caspase-6 inhibitors also reduced caspase-8 and -9 activi-
ties. The abilities of caspase inhibitors to block Stx1-induced
Bid cleavage (Fig. 7B, upper panel) and caspase-8 cleavage
(Fig. 7B, lower panel) were also examined. Caspase-3, -6, and
-8 inhibitors almost completely blocked Bid and caspase-8
cleavage in Stx1-treated THP-1 cells. These data suggest that
in addition to triggering the mitochondrial pathway of apopto-
sis, Stx1 may also activate caspase-8 through a caspase-3- and
caspase-6-dependent mechanism.
Requirement for toxin enzymatic activity and ribotoxic
stress response for Stx1-induced apoptosis. To determine
whether Stx1 binding to Gb3 and/or toxin enzymatic activity is
required for the induction of THP-1 cell apoptosis, we treated
cells with equal amounts of purified Stx1, Stx1 pentameric
B-subunits, or Stx1A (E167Q-R170L), a Stx1 holotoxin con-
taining mutations in the A-subunit active site that reduce Vero
cell cytotoxicity approximately 3  105-fold (32). As shown in
Fig. 8A, after 6 h of treatment with Stx1, 35.8
 2.9% of THP-1
cells were apoptotic as detected by staining with Annexin V
and PI. In contrast, Annexin V and PI staining of cells treated
with B-subunits or Stx1A (E167Q-R170L) were significantly
decreased compared to Stx1-treated cells (3.75 
 0.5% and 4.0

 2.2%, respectively; P  0.01). Caspase-3, -8, and -9 activa-
tion were not detected in cells treated with B-subunits or
Stx1A (E167Q-R170L) (Fig. 8B). To investigate whether the
activation of apoptosis via a caspase-8-dependent, death re-
ceptor-independent mechanism was a general response to pro-
tein synthesis inhibition or is unique to protein synthesis in-
hibitors acting on the ribosomal peptidyltransferase reaction
center to initiate the ribotoxic stress response, we treated
monocytic THP-1 cells with cycloheximide or anisomycin. As
shown in Fig. 8C, even at high cycloheximide doses, apoptosis
of THP-1 cells did not exceed 5.75 
 0.8%. In contrast, ani-
somycin (10 g/ml), a known inducer of the ribotoxic stress
response (17), induced apoptosis in 28.6 
 3.6% of the treated
cells. Thus, binding of Stx1 to membrane Gb3 is not a sufficient
signal for apoptosis in monocytic THP-1 cells. Furthermore, it
would appear that active Stx1 must be transported to the ER,
translocate into the cytoplasm, and trigger the ribotoxic stress
response to initiate apoptotic signaling.
FIG. 5. Effect of caspase inhibitors on m after incubation of
THP-1 cells with Stx1. THP-1 cells were incubated with the caspase-8
inhibitor (C8I) or the general caspase inhibitor (ZVAD-fmk) for 1 h
before treatment with Stx1 (400 ng/ml). Caspase inhibitors were used
at 40 M. After 8 h of incubation with Stx1, cells were stained with
JC-1 reagent and analyzed by flow cytometry. Control cells were not
treated with Stx1. The percentages of cells staining for red and green
fluorescence and green fluorescence only are shown in the scatter
plots. The data shown are representative of at least two independent
experiments.
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FIG. 6. Kinetics of caspase activation and cleavage in Stx1-treated THP-1 cells. (A) Cells were incubated with or without Stx1 (400 ng/ml) for
0 to 24 h. Caspase-3, -8, and -9 activities were then assayed as described in Materials and Methods. Control cells have not been treated with Stx1.
Data shown are means 
 standard errors of the means from three independent experiments (B) After Stx1 stimulation for 0, 2, 4, 6, and 8 h, cell
lysates were subjected to SDS-PAGE and caspase-3, -8, and -9 cleavage was detected by immunoblotting with antibodies directed against the
caspases. Data are representative of three independent experiments.
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DISCUSSION
It is clear that Stxs induce apoptosis in a wide variety of cell
types, including cells of epithelial, endothelial, lymphocytic,
and myelogenous origin (6). Apoptotic cell death is also evi-
dent in tissues of humans suffering from the hemolytic uremic
syndrome (19). While cell death caused by Stxs may be critical
in the pathogenesis of hemorrhagic colitis and systemic vascu-
lar complications, the mechanisms by which the toxins induce
apoptosis remain to be fully characterized. We have shown that
monocytic THP-1 cells are sensitive to the cytotoxic action of
Stxs, with a 50% cytotoxic dose of approximately 14 pg/ml (35).
Monocytic THP-1 cells undergo apoptosis via caspase-3 acti-
vation (21), which is blocked by the general caspase inhibitor
ZVAD-fmk (14). The experiments performed in this study
were designed to further clarify the apoptotic signaling path-
ways necessary for cell death in Stx1-stimulated monocytic
THP-1 cells.
The role of death receptors in signaling for apoptosis has
been well characterized. TNF-/TNFR family or Fas/FasL li-
gation initiates the formation of the death-inducing signaling
complex, an assembly of adaptor proteins, FADD and
TRADD, and procaspase-8. Cleavage of procaspase-8 then
initiates caspase cascades that ultimately trigger apoptosis
(28). Recently, several research groups have shown that in the
absence of death receptors of the TNFR family or Fas,
caspase-8 may still be activated (12, 42). Our study and the
studies of Fujii et al. (12) demonstrate that similar apoptotic
signaling pathways may be triggered by Stxs in monocytic
THP-1 cells and HeLa cells. In contrast, Stx1-induced apopto-
sis of Burkitt’s lymphoma cells appears to involve Fas-medi-
ated signaling (20). Bremner et al. (4) reported that THP-1
cells express FasL in the presence of lipopolysaccharide but
that cell viability was not affected by treatment with anti-Fas
antibodies. Our data show that in the presence or absence of
Stx1, monocytic THP-1 cells fail to express membrane TNFR1,
TNFR2, TNF-, or Fas. However, Stx1 treatment triggers
DNA fragmentation and exposure of membrane phosphatidyl-
serine in the absence of these membrane-expressed death re-
ceptors. Thus, Stxs may induce apoptosis in different cell types
through different signaling mechanisms. Exogenously added
FIG. 7. Role of caspase-6 in Stx1-induced apoptosis. THP-1 cells were pretreated with caspase-3, -6, or -8 inhibitor (40 M) for 1 h and then
treated with Stx1 (400 ng/ml) for 8 h. (A) Caspase activities were measured using specific colorimetric substrates as described in Materials and
Methods. Control cells were not treated with Stx1. Data shown are means 
 standard errors of the means from three independent experiments.
*, **, and ***, significant differences (P  0.01) within treatment groups relative to control (unstimulated) cells. (B) Cell lysates were separated
by SDS-PAGE, and Bid (upper panel) and caspase-8 (lower panel) cleavage was detected using anti-Bid and anti-caspase-8 antibodies. Control
cells were not treated with Stx1. A representative immunoblot from three independent experiments is shown.
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rhTNF- did not induce THP-1 cell apoptosis, and anti-TNF-
or anti-TNFR1 neutralizing antibodies failed to inhibit Stx1-
mediated apoptosis. As expected, treatment of cells with
ZVAD-fmk and a caspase-3 specific inhibitor reduced Stx1-
mediated DNA fragmentation and Annexin V staining, but we
also noted that a caspase-8 inhibitor blocked these indicators
of apoptosis. While we cannot rule out the possibility of poorly
defined, novel death receptors participating in Stx1-mediated
FIG. 8. Requirement for Stx1 enzymatic activity and the ribotoxic stress response in Stx1-induced apoptosis of THP-1 cells. Cells were
incubated with Stx1 or Stx1A (E167Q-R170L) or Stx1 B-subunits (400 ng/ml and 800 ng/ml, respectively) for 6 h. (A) Percent apoptosis was
analyzed by flow cytometry following Annexin V and PI staining. Data shown are means 
 standard errors of the means from at least two
independent experiments. (B) Caspase-3, -8 and -9 activities were measured using specific colorimetric substrates as described in Materials and
Methods. Control cells were not treated with Stx1, Stx1A, or Stx1 B-subunits. Data shown are means 
 standard errors of the means from three
independent experiments. *, **, and ***, significant differences (P  0.01) within treatment groups relative to Stx1-treated cells. (C) Cells were
treated with Stx1, cycloheximide (10 to 200 M), or anisomycin (0.1 to 10 g/ml) for 5 h, and apoptosis was measured by flow cytometry following
Annexin V and PI staining. CHX, cycloheximide; Aniso, anisomycin.
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apoptosis induction, our data suggest that Stx1 induces THP-1
cell apoptosis in a TNFR/Fas-independent, caspase-8-depen-
dent manner.
Activated caspase-8 may directly trigger the activation of
executioner caspases, such as caspase-3 (1), or may trigger
apoptosis through the mitochondrial pathway by cleavage of
Bid (9). Once cleaved, tBid translocates from the cytosol to the
mitochondrial outer membrane, mediating the homo-oli-
gomerization of Bak and Bax proteins, the reduction in mito-
chondrial membrane potential, and the release of cytochrome
c (51). Release of mitochondrial cytochrome c forms the ap-
optosome, a complex containing procaspase-9, Apaf-1, ATP,
and cytochrome c. Procaspase-9 is cleaved, which then cleaves
procaspase-3 (23, 53). We showed that Bid cleavage started 4 h
after exposure of THP-1 cells to Stx1, with a 50% reduction in
the uncleaved molecule by 8 h of treatment. Disruption of
m and cytochrome c release correlated with Bid cleavage.
Furthermore, pretreatment of THP-1 cells with caspase-8 in-
hibitor almost completely prevented mitochondrial membrane
disruption. These data indicate that caspase-8 is involved in
Bid cleavage and cytochrome c release in Stx1-treated THP-1
cells. In addition, caspase-8 activation occurs upstream of
caspase-9 and -3 activation.
It should be noted that we have observed Stx1-induced
THP-1 cell death beginning at 4 h (14), but cytochrome c
release was first evident 6 h after toxin treatment. These results
suggest that caspase-8 may also directly activate caspase-3,
while the mitochondrial pathway of apoptosis induction is trig-
gered with slightly slower kinetics. Our data suggest that
caspase-6 may be involved in the direct activation of caspase-8.
Caspase-6 is a lamin protease, and activated lamin A induces
nuclear disassembly and chromatin condensation (37). Fur-
thermore, procaspase-6 is activated by caspase-3 and, in turn,
activates procaspase-8 (7). Kojio et al. (21) showed a sixfold
increase in caspase-6 activity in Stx-treated THP-1 cells, and
we show here that a caspase-6 inhibitor reduces apoptosis by
approximately 50%. To demonstrate a linkage among
caspase-3, -6, and -8, we measured Stx1-induced caspase activ-
ities and procaspase cleavage in the presence or absence of
specific inhibitors for each of the caspases. Although the per-
centages of inhibition differed among the different treatments,
all the caspase-3, -6, and -8 inhibitors blocked caspase-3, -8,
and -9 activities and procaspase-8 cleavage. Thus, blocking
caspase-3 or -6 prevents caspase-8 activation and blocks Bid
cleavage. These data suggest that Stx1 may trigger separate
apoptosis signaling pathways in THP-1 cells. These signaling
pathways are depicted in Fig. 9.
Kojio et al. (21) reported caspase-3 activity peaking 5 h after
exposure of THP-1 cells to Stx1. We measured caspase-3, -8,
and -9 activities from 0 to 24 h after toxin treatment and found
that all caspase activities reached the highest levels after 8 h.
For the remaining 16 h of the experiments, caspase activities
appeared to return to basal levels, although we have shown
significant cell death occurring within this time period (14).
Caspase-2 activity was reported to be increased 12-fold in
Stx1-treated THP-1 cells (21), and we also found increased
FIG. 9. Proposed model of Stx1-induced apoptosis signaling pathways in monocytic THP-1 cells. See text for additional details.
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caspase-2 activity in Stx1-treated cells (data not shown). How-
ever, we found that inhibition of caspase-2 activity failed to
decrease Stx1-mediated DNA laddering or Annexin V stain-
ing. The role of caspase-2 in apoptosis is controversial. Pro-
caspase-2 is constitutively expressed in the nucleus and Golgi
apparatus (26, 52). DNA damage by etoposide (an inhibitor of
nuclear topoisomerase 2), the binding of TNF- to TNFR1,
and the activation of caspase-3 have all been shown to activate
caspase-2 (33, 36). However, cleavage may not be required for
caspase-2 activation. Procaspase-2 may oligomerize and be-
come partially activated, although the role of procaspase-2
aggregates in apoptosis is unclear (2). Recently, Golgin-160, a
Golgi apparatus-localized macromolecular complex, has been
shown to be a substrate for caspase-2 involved in the disassem-
bly of the Golgi complex (26). Whether treatment of THP-1
cells with Stx1 results in proteolysis of Golgin-160, and whether
cleaved Golgin-160 is involved in apoptosis, will require addi-
tional experiments.
The treatment of Ramos Burkitt’s lymphoma and astrocy-
toma cells with Stx B-subunits or anti-Gb3 monoclonal anti-
body has been reported to induce apoptosis and activate pro-
caspase-8 (20). Thus, for these cells, binding of toxin receptors
at the cell surface may generate sufficient signals to activate
programmed cell death cascades. We show here that purified
Stx1 B-subunits and an enzymatic (active site) mutant toxin are
incapable of inducing apoptosis or caspase-3, -8, and -9 activ-
ities in monocytic THP-1 cells. Inhibition of the formation of
functional Golgi complexes using brefeldin A has been shown
to inhibit Stx1-induced caspase-3 activity and DNA fragmen-
tation in THP-1 cells (21). Together, these data suggest that
Stxs must be internalized and undergo retrograde transport
through the Golgi apparatus to the ER, and the functional
toxin A-subunit fragments must be translocated into the cyto-
plasm in order to trigger the signals necessary for apoptosis
induction.
A key feature of the apoptotic pathways triggered by Stxs
that remains to be characterized is the linkage between protein
synthesis inhibition and the activation of caspases. A family of
ribosome inactivating proteins, including Stxs, has been shown
to induce the ribotoxic stress response (5, 10, 17, 41). As a
result of the highly specific 28S rRNA depurination reaction
mediated by Stxs, the stress-activated protein kinase cascades,
JNK and p38, are activated. These mitogen-activated protein
kinases (MAPKs) phosphorylate a number of downstream sub-
strates, leading to activation of transcriptional factors such as
NF-B and AP-1. In response to Stxs, therefore, the cellular
transcriptome may be rapidly altered by transcriptional and
posttranscriptional mechanisms. The p38 MAPK cascade has
also been reported to regulate the stability of some mRNA
transcripts (50). Our data suggest that the activation of apo-
ptotic signaling is not a general response to protein synthesis
inhibition but that the ribotoxic stress response may be selec-
tively involved in triggering caspase-8- and mitochondrion-de-
pendent programmed cell death. Ribosome inactivation may
not be the sole determinant in triggering apoptosis; rather,
toxin effects directed to the ER membrane may contribute to
signaling. Jimbo et al. (18) showed that ER stress initiated
procaspase-8 activation by direct interaction of caspase-8 with
ER membrane proteins. Bap31 is a polytopic integral mem-
brane protein of the ER and a substrate for caspase-8 activity.
Bap31 may interact with Bcl-2 to inhibit the interaction be-
tween procaspase-8 and Bap31. However, if Bap31 associates
with procaspase-8 in the absence of Bcl-2, then procaspase-8
and Bap31 are cleaved and programmed cell death may be
initiated (3, 30). Even though the precise role of Bap31 in
apoptosis remains to be elucidated, it may explain how pro-
caspase-8 is activated in the absence of death receptor expres-
sion by THP-1 cells.
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